To evaluate and compare prospectively the effects of Biliopancreatic Diversion Long Limb (BPDLL) and Laparoscopic Sleeve Gastrectomy (LSG) on resolution of diabetes mellitus type 2.
Twelve patients with diabetes mellitus type 2 (DM 2) and body mass index (BMI)\> 50kg/m2) will undergo BPDLL and 12 twelve patients with DM 2 and BMI 40-50 kg/m2 will undergo LSG. The patients will be evaluated before and 1, 3 and 12 months after surgery with an oral glucose tolerance test. The investigators aim to investigate the effects of surgery on diabetes resolution, hypertension, dyslipidemia, and also on fasting, and glucose-stimulated insulin, glucagon, ghrelin, peptide-YY and glucagon-like peptide-1 (GLP-1) responses during during an oral glucose tolerance test (OGTT). Resolution of diabetes mellitus will be evaluated according to the criteria of American Diabetes Association with an OGTT. The effects on appetite and satiety will be also evaluated with the use of visual analog scores.
Study Type
OBSERVATIONAL
Enrollment
24
University Hospital of Patras
Rio, Achaia, Greece
University Hospital of Patras
Rio, Achaia, Greece
Diabetes resolution at 12 months after surgery
Time frame: 12 months after surgery
Weight loss at 12 months after surgery
Time frame: 12 months after surgery
Changes of GLP-1 response to glucose
Time frame: 12 months after surgery
Changes in ghrelin levels
Time frame: 12 months after surgery
Changes in PYY response to glucose
Time frame: 12 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.